Effects of Estrogen on Growth Hormone Following Clonidine Stimulation

Darrell M. Wilson, Riico J N Dotson, E. Kirk Neely, Pinchas Cohen, Raymond L. Hintz, Ronald (Ron) Rosenfeld

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

To test the usefulness of estrogen priming to enhance the growth hormone response following stimulation with clonidine hydrochloride in short children. —Randomizedand patient series. —Pediatricendocrine clinic in a referral center. —Seventy-threechildren between 1.8 and 15.4 years of age with growth problems who underwent clonidine GH stimulation tests were randomly assigned to receive either estrogen pretreatment or no pretreatment. An additional 49 subjects, seen before or after the randomized study and who did not receive conjugated estrogen, are also described. —Consecutivesample. —Estrogenpretreatment consisted of 2.5 mg of conjugated estrogen to be taken the evening before and the morning of the clonidine GH stimulation test. Growth hormone concentrations were determined before and 60 and 90 minutes after the subjects received oral clonidine hydrochloride y a laboratory blinded to the subject's estrogen status. Growth hormone concentrations greater than 10 μg/Lwere considered normal. —Eightof the 73 subjects failed both clonidine and arginine-insulin GH stimulation tests. We analyzed the GH data from the 65 GH-sufficient subjects to determine the effect of estrogen pretreatment on the specificity of the clonidine GH stimulation test. There were no statistically significant differences in the mean GH concentrations between the two groups at any time point during the test. —Ourdata demonstrate that estrogen priming does not improve the diagnostic yield of clonidine GH stimulation tests.

Original languageEnglish (US)
Pages (from-to)63-65
Number of pages3
JournalAmerican Journal of Diseases of Children
Volume147
Issue number1
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Clonidine
Growth Hormone
Estrogens
Conjugated (USP) Estrogens
Arginine
Referral and Consultation
Insulin
Growth

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Wilson, D. M., Dotson, R. J. N., Neely, E. K., Cohen, P., Hintz, R. L., & Rosenfeld, R. R. (1993). Effects of Estrogen on Growth Hormone Following Clonidine Stimulation. American Journal of Diseases of Children, 147(1), 63-65. https://doi.org/10.1001/archpedi.1993.02160250065019

Effects of Estrogen on Growth Hormone Following Clonidine Stimulation. / Wilson, Darrell M.; Dotson, Riico J N; Neely, E. Kirk; Cohen, Pinchas; Hintz, Raymond L.; Rosenfeld, Ronald (Ron).

In: American Journal of Diseases of Children, Vol. 147, No. 1, 1993, p. 63-65.

Research output: Contribution to journalArticle

Wilson, DM, Dotson, RJN, Neely, EK, Cohen, P, Hintz, RL & Rosenfeld, RR 1993, 'Effects of Estrogen on Growth Hormone Following Clonidine Stimulation', American Journal of Diseases of Children, vol. 147, no. 1, pp. 63-65. https://doi.org/10.1001/archpedi.1993.02160250065019
Wilson, Darrell M. ; Dotson, Riico J N ; Neely, E. Kirk ; Cohen, Pinchas ; Hintz, Raymond L. ; Rosenfeld, Ronald (Ron). / Effects of Estrogen on Growth Hormone Following Clonidine Stimulation. In: American Journal of Diseases of Children. 1993 ; Vol. 147, No. 1. pp. 63-65.
@article{67e81cfb4fe8459cb346f08b85813c90,
title = "Effects of Estrogen on Growth Hormone Following Clonidine Stimulation",
abstract = "To test the usefulness of estrogen priming to enhance the growth hormone response following stimulation with clonidine hydrochloride in short children. —Randomizedand patient series. —Pediatricendocrine clinic in a referral center. —Seventy-threechildren between 1.8 and 15.4 years of age with growth problems who underwent clonidine GH stimulation tests were randomly assigned to receive either estrogen pretreatment or no pretreatment. An additional 49 subjects, seen before or after the randomized study and who did not receive conjugated estrogen, are also described. —Consecutivesample. —Estrogenpretreatment consisted of 2.5 mg of conjugated estrogen to be taken the evening before and the morning of the clonidine GH stimulation test. Growth hormone concentrations were determined before and 60 and 90 minutes after the subjects received oral clonidine hydrochloride y a laboratory blinded to the subject's estrogen status. Growth hormone concentrations greater than 10 μg/Lwere considered normal. —Eightof the 73 subjects failed both clonidine and arginine-insulin GH stimulation tests. We analyzed the GH data from the 65 GH-sufficient subjects to determine the effect of estrogen pretreatment on the specificity of the clonidine GH stimulation test. There were no statistically significant differences in the mean GH concentrations between the two groups at any time point during the test. —Ourdata demonstrate that estrogen priming does not improve the diagnostic yield of clonidine GH stimulation tests.",
author = "Wilson, {Darrell M.} and Dotson, {Riico J N} and Neely, {E. Kirk} and Pinchas Cohen and Hintz, {Raymond L.} and Rosenfeld, {Ronald (Ron)}",
year = "1993",
doi = "10.1001/archpedi.1993.02160250065019",
language = "English (US)",
volume = "147",
pages = "63--65",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "1",

}

TY - JOUR

T1 - Effects of Estrogen on Growth Hormone Following Clonidine Stimulation

AU - Wilson, Darrell M.

AU - Dotson, Riico J N

AU - Neely, E. Kirk

AU - Cohen, Pinchas

AU - Hintz, Raymond L.

AU - Rosenfeld, Ronald (Ron)

PY - 1993

Y1 - 1993

N2 - To test the usefulness of estrogen priming to enhance the growth hormone response following stimulation with clonidine hydrochloride in short children. —Randomizedand patient series. —Pediatricendocrine clinic in a referral center. —Seventy-threechildren between 1.8 and 15.4 years of age with growth problems who underwent clonidine GH stimulation tests were randomly assigned to receive either estrogen pretreatment or no pretreatment. An additional 49 subjects, seen before or after the randomized study and who did not receive conjugated estrogen, are also described. —Consecutivesample. —Estrogenpretreatment consisted of 2.5 mg of conjugated estrogen to be taken the evening before and the morning of the clonidine GH stimulation test. Growth hormone concentrations were determined before and 60 and 90 minutes after the subjects received oral clonidine hydrochloride y a laboratory blinded to the subject's estrogen status. Growth hormone concentrations greater than 10 μg/Lwere considered normal. —Eightof the 73 subjects failed both clonidine and arginine-insulin GH stimulation tests. We analyzed the GH data from the 65 GH-sufficient subjects to determine the effect of estrogen pretreatment on the specificity of the clonidine GH stimulation test. There were no statistically significant differences in the mean GH concentrations between the two groups at any time point during the test. —Ourdata demonstrate that estrogen priming does not improve the diagnostic yield of clonidine GH stimulation tests.

AB - To test the usefulness of estrogen priming to enhance the growth hormone response following stimulation with clonidine hydrochloride in short children. —Randomizedand patient series. —Pediatricendocrine clinic in a referral center. —Seventy-threechildren between 1.8 and 15.4 years of age with growth problems who underwent clonidine GH stimulation tests were randomly assigned to receive either estrogen pretreatment or no pretreatment. An additional 49 subjects, seen before or after the randomized study and who did not receive conjugated estrogen, are also described. —Consecutivesample. —Estrogenpretreatment consisted of 2.5 mg of conjugated estrogen to be taken the evening before and the morning of the clonidine GH stimulation test. Growth hormone concentrations were determined before and 60 and 90 minutes after the subjects received oral clonidine hydrochloride y a laboratory blinded to the subject's estrogen status. Growth hormone concentrations greater than 10 μg/Lwere considered normal. —Eightof the 73 subjects failed both clonidine and arginine-insulin GH stimulation tests. We analyzed the GH data from the 65 GH-sufficient subjects to determine the effect of estrogen pretreatment on the specificity of the clonidine GH stimulation test. There were no statistically significant differences in the mean GH concentrations between the two groups at any time point during the test. —Ourdata demonstrate that estrogen priming does not improve the diagnostic yield of clonidine GH stimulation tests.

UR - http://www.scopus.com/inward/record.url?scp=0027469339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027469339&partnerID=8YFLogxK

U2 - 10.1001/archpedi.1993.02160250065019

DO - 10.1001/archpedi.1993.02160250065019

M3 - Article

VL - 147

SP - 63

EP - 65

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 1

ER -